Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines, research innovation and other news as we work to support patients fighting serious …

2024年4月25日 · Bristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025, including laying off more than 2,000 …

Receive updated news from preferred websites, which are sent directly to the user's news reader. This includes the headlines, summaries and links to the full article on the website.

2025年2月6日 · Bristol Myers Squibb is expanding its existing strategic productivity initiative to include approximately $2 billion in additional annualized cost savings by the end of 2027. …

Get the latest Bristol-Myers Squibb Company (BMY) stock news and headlines to help you in your trading and investing decisions.

2024年1月23日 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc. …

Access information and multimedia resources about Bristol Myers Squibb as we transform lives through science. Get an overview of our company facts, financials and leadership team. Visit …

2025年2月6日 · BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2,200 job cuts, adding a target of another $2bn by end-2027.

2025年2月6日 · Bristol Myers Squibb’s strategic re-organization rolls on with an additional $2 billion in savings through 2027 on top of an ongoing program that had targeted $1.5 billion in …

2025年3月11日 · Bristol Myers Squibb (BMS) has agreed to acquire its longtime cell therapy partner 2seventy bio in a deal valued at $286m. ... The market reacted favourably with …